Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics for type 2 diabetes: practical considerations for study design.

Journal of diabetes science and technology - 1 Jul 2009

Vella Adrian

Abstract excerpt

There is a relative dearth of studies designed to elucidate genetic variation that can explain differences in the response to diabetes pharmacotherapy. When designing such studies, appropriate consideration of the various nongenetic variables that can affect the treatment response is necessary. In addition, disease stage and prior pharmacotherapy also influence drug efficacy. Selecting the appropriate genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 2
Share to Genetic Predisposition to Disease
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Research Design

Source

Open in PubMed Open full text

Identifiers

PMID: 20144317
DOI: 10.1177/193229680900300415
PMCID: PMC2769969

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics for type 2 diabetes: practical considerations for study design.PMID 20144317Read ↗

Pharmacogenetics: potential role in the treatment of diabetes and obesity.Semantic proximity Read ↗

Genetic basis of type 2 diabetes mellitus: implications for therapy.Semantic proximity Read ↗

Pharmacogenetics of Type 2 Diabetes—Progress and ProspectsSemantic proximity Read ↗

Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?Semantic proximity Read ↗

Pharmacogenetic studies update in type 2 diabetes mellitusSemantic proximity Read ↗

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicineSemantic proximity Read ↗

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.Semantic proximity Read ↗

Genetic susceptibility to type 2 diabetes and implications for antidiabetic therapy.Semantic proximity Read ↗

Metformin Pharmacogenomics: Current Status and Future DirectionsSemantic proximity Read ↗

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 DiabetesSemantic proximity Read ↗

Genetic susceptibility to type 2 diabetes and implications for therapy.Semantic proximity Read ↗

Diabetes: Genetic variation underpins metformin response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.